Phase I trial of Lipovaxin-MM, a novel dendritic cell-targeted liposomal vaccine for malignant melanoma
Gargett, Tessa, Abbas, M. Nazim, Rolan, Paul, Price, Jason D., Gosling, Katharine M., Ferrante, Antonio, Ruszkiewicz, Andrew, Atmosukarto, Ines I. C., Altin, Joseph, Parish, Christopher R., Brown, Michael P.
Published in Cancer Immunology, Immunotherapy (01.09.2018)
Published in Cancer Immunology, Immunotherapy (01.09.2018)
Get full text
Journal Article